The Tyrosine Protein Kinase Fyn Market is expected to grow at a healthy CAGR during the forecast period. In 2020, North America led the Tyrosine Protein Kinase Fyn market with over 30% share, due to high cancer rates and healthcare advancements. The U.S. alone saw about 1.8 million new cancer cases. The Asia-Pacific market is expected to grow significantly, driven by rising demand for advanced healthcare solutions.